VEGF Classification

NewsGuard 100/100 Score

VEGF (vascular endothelial growth factor) is a signal protein that promotes the growth of new blood vessels. VEGF forms part of the system that restores the blood supply to cells and tissues when they are deprived of oxygenated blood due to compromised blood circulation.

VEGF proteins form a particular sub-family of growth factors referred to as the platelet-derived growth factor family of cystine-knot growth factors. They are key signalling proteins involved in two different types of blood vessel formation, namely vasculogenesis and angiogenesis. Vasculogenesis refers to the de novo formationof vessels in the development of the embryo’s circulatory system, while angiogenesis describes the formation of blood vessels from vasculature that already exists.

The most important member of the VEGF family is VEGF-A. Other factors in the family include VEGF-B, VEGF-C, VEGF-D and placenta growth factor (PlGF). Other VEGF related proteins include VEGF-E encoded by viruses and VEGF-F found in the venom of some snakes.

The different roles of the various VEGF proteins are described below:

  • VEGF-A – VEGF-A is required for angiogenesis, specifically for the creation of the blood vessel lumen and fenestrations; for promoting the migration and mitosis of endothelial cells, and stimulating matrix metalloproteinase and αvβ3 activity. This protein is also chemotactic for granulocytes and macrophages and stimulates vasodilation through the release of nitric oxide.
  • VEGF-B – This protein is required for blood vessel formation in the embryo (embryonic angiogenesis).
  • VEGF-C – This protein is key to the formation of new lymphatic vessels from those already existing.
  • VEGF-D – This form of VEGF is required for the development of lymphatic vessels that surround the bronchioles or air passages within the lungs.
  • PlGF – This form of VEGF is required for vasculogenesis and angiogenesis.

Further Reading

Last Updated: Aug 18, 2023

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2023, August 18). VEGF Classification. News-Medical. Retrieved on April 16, 2024 from https://www.news-medical.net/life-sciences/VEGF-Classification.aspx.

  • MLA

    Mandal, Ananya. "VEGF Classification". News-Medical. 16 April 2024. <https://www.news-medical.net/life-sciences/VEGF-Classification.aspx>.

  • Chicago

    Mandal, Ananya. "VEGF Classification". News-Medical. https://www.news-medical.net/life-sciences/VEGF-Classification.aspx. (accessed April 16, 2024).

  • Harvard

    Mandal, Ananya. 2023. VEGF Classification. News-Medical, viewed 16 April 2024, https://www.news-medical.net/life-sciences/VEGF-Classification.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Fecal microbiota transplantation boosts survival in metastatic colorectal cancer treatment